| Fiscal period | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
| Period End Date | 11/30/2025 | 11/30/2024 | 11/30/2023 | 11/30/2022 | 11/30/2021 | 11/30/2020 | 11/30/2019 | 11/30/2018 | 11/30/2017 | 11/30/2016 |
| Revenue | 3,473.59 | 3,568.74 | 3,510.93 | 3,749.18 | 3,278.03 | 2,790.27 | 2,897.00 | 3,041.00 | 2,306.04 | 2,094.61 |
| Total Revenues | 3,473.59 | 3,568.74 | 3,510.93 | 3,749.18 | 3,278.03 | 2,790.27 | 2,897.00 | 3,041.00 | 2,306.04 | 2,094.61 |
| Cost of sales | 2,392.93 | 2,506.86 | 2,502.04 | 2,785.48 | 2,432.71 | 2,033.62 | 2,090.08 | 2,204.11 | 1,702.87 | 1,484.80 |
| Gross Profit | 1,080.66 | 1,061.88 | 1,008.90 | 963.70 | 845.32 | 756.65 | 806.92 | 836.89 | 603.17 | 609.80 |
| Selling, general and administrative expenses | 725.59 | 713.66 | 653.76 | 640.98 | 592.71 | 538.33 | 580.93 | 582.13 | 477.03 | 407.64 |
| Interest expense | 133.35 | 133.12 | 134.60 | 91.52 | 78.09 | 86.78 | 103.29 | 110.99 | 43.70 | 27.36 |
| Special charges | -- | -- | -- | -- | -- | -- | -- | -- | -- | (0.17) |
| Asset impairment charges | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Goodwill impairment charges | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gains from sales of assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Interest income | 4.82 | 4.68 | 3.94 | 7.78 | 9.48 | 11.42 | 12.18 | 11.77 | -- | -- |
| Other income (expense), net | (11.13) | (37.12) | 9.68 | 12.95 | 32.86 | 15.40 | 37.94 | 1.18 | (23.74) | (7.55) |
| Interest income | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Other, net | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Foreign currency transaction losses, net | -- | -- | -- | -- | -- | (3.08) | -- | -- | -- | -- |
| Gains (losses) on trading securities | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Amortization of investments in partnerships that generate low-income housing tax credits accounted for under the cost me | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Amortization of low income housing | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gains on investments and company owned life insurance | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Roanoke litigation settlement | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Gain on disposal of fixed assets | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Pre-Tax Income: United States | -- | (46.06) | -- | -- | -- | 20.33 | -- | -- | (35.17) | 76.20 |
| Non-U.S | -- | 228.73 | -- | -- | -- | 138.03 | -- | -- | 93.87 | 91.23 |
| Income before income taxes, minority interests and incomefrom equity investments | 215.42 | 182.66 | 234.16 | 251.93 | 216.85 | 158.36 | 172.83 | 156.73 | 58.70 | 167.43 |
| Current- U.S. Federal | 23.75 | 14.15 | 18.35 | 12.18 | 10.31 | 5.24 | 9.12 | 9.65 | 0.44 | 14.52 |
| Current: State | 5.05 | 4.10 | 5.53 | 3.39 | 2.27 | 1.32 | 3.29 | 1.60 | 0.02 | 2.79 |
| Income taxes | 67.13 | 56.38 | 93.53 | 77.19 | 63.03 | 41.92 | 49.41 | (6.36) | 9.09 | 50.44 |
| Deferred: State | (2.91) | (4.44) | (4.11) | (1.77) | (0.35) | (4.11) | 0.13 | (0.20) | (1.47) | 1.10 |
| Current- Non-U.S | 78.93 | 92.72 | 87.45 | 63.75 | 57.80 | 56.54 | 47.85 | 37.98 | 29.56 | 27.79 |
| Deferred- U.S. Federal | (33.71) | (44.78) | (0.10) | 8.15 | (6.89) | (4.71) | (0.43) | (50.12) | (8.32) | 6.44 |
| Deferred- Non-U.S | (3.98) | (5.37) | (13.59) | (8.52) | (0.10) | (12.36) | (10.55) | (5.27) | (11.15) | (2.20) |
| Minority interests in (income) loss of subsidiaries | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Income from equity investments | 3.78 | 4.11 | 4.36 | 5.67 | 7.66 | 7.35 | 7.42 | 8.15 | 8.68 | 7.39 |
| Income from Continuing Operations | -- | -- | -- | -- | -- | -- | -- | -- | 58.29 | 124.38 |
| Income from discontinued operations | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cumulative effect of accounting change | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income including non-controlling interests | 152.07 | 130.40 | 144.99 | 180.41 | 161.48 | 123.79 | 130.84 | 171.23 | 58.29 | 124.38 |
| Net (income) loss attributable to non-controlling interest | 0.11 | 0.14 | 0.08 | 0.09 | 0.08 | 0.07 | 0.03 | 0.02 | 0.05 | 0.25 |
| Net Income (Loss) Available to Common Shareholders | 151.97 | 130.26 | 144.91 | 180.31 | 161.39 | 123.72 | 130.82 | 171.21 | 58.24 | 124.13 |
| Continuing operations - Basic | -- | -- | -- | -- | -- | -- | -- | -- | 1.16 | 2.48 |
| Discontinued operations - Basic | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cumulative effect of accounting change - Basic | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income - Basic | 2.78 | 2.37 | 2.67 | 3.37 | 3.05 | 2.38 | 2.57 | 3.38 | 1.16 | 2.48 |
| Continuing operations - Diluted | -- | -- | -- | -- | -- | -- | -- | -- | 1.13 | 2.42 |
| Discontinued operations - Diluted | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Cumulative effect of accounting change - Diluted | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Net income - Diluted | 2.75 | 2.30 | 2.59 | 3.26 | 2.97 | 2.36 | 2.52 | 3.29 | 1.13 | 2.42 |
| Weighted-average common shares outstanding: Basic | 54.60 | 54.93 | 54.33 | 53.58 | 52.89 | 52.04 | 50.92 | 50.59 | 50.37 | 50.14 |
| Weighted-average common shares outstanding: Diluted | 55.36 | 56.63 | 55.96 | 55.27 | 54.32 | 52.52 | 51.98 | 51.98 | 51.62 | 51.27 |